Jordan’s coronavirus response took a surprise turn on Sunday when the government announced that it will buy an unspecified amount of the Chinese Sinopharm vaccine through an Emirati company.
The development thrusts Jordan in the east-west competition for the vaccine market. It comes after the government said it had bought one million doses of the American Pfizer-BioNTech vaccine.
Health Minister Nizar Obeidat said a shipment of the Sinopharm vaccine arrived in Jordan this morning from the UAE, with the first doses to be given on Wednesday.
“If you trust me, I have taken it personally and I can swear to that,” Mr Obeidat told reporters in Amman.
Mr Obeidat said the first shipment of the Pfizer-BioNTech vaccine would arrive this week.
“All vaccines being made available in Jordan are safe and effective enough. We deal with all vaccines equally,” he said.
The government has come under criticism for its coronavirus response since deaths and infections rose sharply in October.
The authorities waited to reimpose a curfew in November, conducting elections for the mostly nominal parliament in between. It has closed schools but allowed restaurants and businesses to remain open despite a surge of infections.
Security forces released Jordanian journalist Jamal Haddad this month after he was arrested for reporting on a local website that senior officials had taken the Pfizer-BioNTech vaccine.
Referring to the Abu Dhabi company G42, Mr Obeidat said “it has been agreed with the Emirati company in charge of distributing the Chinese vaccine to provide us with extra volumes” of the Sinopharm vaccine.
Sinopharm has sold at least three million doses of its vaccine to the UAE.
Mr Obeidat said the Sinopharm vaccine volumes the Jordanian government expects to purchase will be revealed “when the whole deal is done”.
“We cannot announce that today because the negotiations are ongoing,” he said.
The latest official data shows that more than 4,000 people have died from Covid-19 in Jordan, with 307,000 infections recorded. Its population is about 10 million.
Mr Obeidat said the initial aim was to vaccinate two million people, and that under the plan, “no person will be allowed to take the right of others” to the vaccine.


